South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has unveiled ...
Germany-based Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) ...
South Korea-based Celltrion has signed an agreement with Eli Lilly to acquire a biopharmaceutical drug substance (DS) ma...
China's WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has ann...
Fujifilm Biotechnologies has announced the opening of its manufacturing site in Holly Springs, North Carolina, US. The n...
UK-based eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Thailand's Si...
Taiwan-based EirGenix has announced a new milestone in collaboration with Merck. What began as a trusted supplier–...
Celltrion Pharm, a South Korean biopharmaceutical firm, has inked a strategic trilateral agreement with a multinational ...
The founder and long-standing CEO of PlasmidFactory GmbH, Dr. Martin Schleef, was honored in Düsseldorf with the In...
Strides Pharma Science has announced that its step-down, wholly owned subsidiary, Strides Pharma Global Pte. Limited, Si...
ChemPartner, a leading global Contract Research Organization (CRO) and Contract Development and Manufacturing Organizati...
China's BioDlink has announced that its Bevacizumab Injection has obtained marketing authorisation from&n...
Bionova Scientific, a full-service biologics contract development and manufacturing organization (CDMO) and subsidiary o...
WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced t...
ProBio, a leading contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, ...
Australia-based contract development and manufacturing organisations Viral Vector Manufacturing Facility (VVMF) and...
Thermo Fisher Scientific Inc. has announced an expansion of their strategic partnership with Sanofi to enable additional...
South Korea-based biopharmaceutical company Samsung Bioepis has published a whitepaper titled ‘Solving the Biosimi...
